BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24477166)

  • 1. Magnetic resonance imaging using gadolinium-based contrast agents.
    Mitsumori LM; Bhargava P; Essig M; Maki JH
    Top Magn Reson Imaging; 2014 Feb; 23(1):51-69. PubMed ID: 24477166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI contrast agents: basic chemistry and safety.
    Hao D; Ai T; Goerner F; Hu X; Runge VM; Tweedle M
    J Magn Reson Imaging; 2012 Nov; 36(5):1060-71. PubMed ID: 23090917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis.
    Kaewlai R; Abujudeh H
    AJR Am J Roentgenol; 2012 Jul; 199(1):W17-23. PubMed ID: 22733927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance contrast agents for liver imaging.
    Bashir MR
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):283-93. PubMed ID: 25086930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium contrast agent selection and optimal use for body MR imaging.
    Guglielmo FF; Mitchell DG; Gupta S
    Radiol Clin North Am; 2014 Jul; 52(4):637-56. PubMed ID: 24889165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of magnetic resonance imaging contrast agents in the liver and biliary tract.
    Lebedis C; Luna A; Soto JA
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadolinium-based magnetic resonance contrast agents for neuroradiology: an overview.
    Kanal E
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):625-31. PubMed ID: 23088942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadofullerene MRI contrast agents.
    Bolskar RD
    Nanomedicine (Lond); 2008 Apr; 3(2):201-13. PubMed ID: 18373426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of fat suppression in gadolinium-enhanced magnetic resonance neuroimaging.
    D'Anjou MA; Carmel EN; Tidwell AS
    Vet Radiol Ultrasound; 2011; 52(1 Suppl 1):S85-90. PubMed ID: 21392161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.
    Ghiassi KB; Olmstead MM; Balch AL
    Dalton Trans; 2014 May; 43(20):7346-58. PubMed ID: 24522668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging.
    Alric C; Taleb J; Le Duc G; Mandon C; Billotey C; Le Meur-Herland A; Brochard T; Vocanson F; Janier M; Perriat P; Roux S; Tillement O
    J Am Chem Soc; 2008 May; 130(18):5908-15. PubMed ID: 18407638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology and MRI contrast enhancement.
    Matson ML; Wilson LJ
    Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-based contrast agents in pediatric magnetic resonance imaging.
    Gale EM; Caravan P; Rao AG; McDonald RJ; Winfeld M; Fleck RJ; Gee MS
    Pediatr Radiol; 2017 May; 47(5):507-521. PubMed ID: 28409250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MR imaging in neuroimaging.
    Kim BS; Gutierrez JE
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):649-85. PubMed ID: 23088944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.